Literature DB >> 1837334

Lymphocyte subpopulations and function in childhood IgA nephropathy.

A Kameda1, N Yoshikawa, S Shiozawa, K Doi, H Nakamura.   

Abstract

In order to examine T lymphocyte function in childhood IgA nephropathy, 13 patients and 10 age-matched control subjects were studied. T lymphocyte function was examined in terms of in vitro immunoglobulin synthesis by peripheral blood mononuclear cells (PBMC) and CD4-depleted (suppressor-rich) and CD8-depleted (helper-rich) PBMC in both unstimulated and pokeweed mitogen (PWM) and Staphylococcus aureus Cowan I (SAC) stimulated cultures. T lymphocyte subpopulations were examined by two-color immunofluorescence analysis using Fluorescein-Activated Cell Sorter (FACS). Children with IgA nephropathy showed (1) a significant increase in IgA synthesis by PBMC with or without mitogen stimulation, (2) a significant increase in IgG and IgA synthesis by CD4-depleted (suppressor-rich) PBMC, (3) a significant increase in IgG and IgA synthesis by CD8-depleted (helper-rich) PBMC, and (4) a significant decrease in suppressor-inducer T cells (Leu3a+Leu8+). These results suggest that a decrease in suppressor-inducer T cells, impaired suppressor T cell function and hyperactivity of helper T cell function are responsible for the increase in IgA production in children with IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1837334     DOI: 10.1159/000186642

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

Review 1.  T cell subsets in glomerular diseases.

Authors:  S Florquin; M Goldman
Journal:  Springer Semin Immunopathol       Date:  1994

Review 2.  IgA nephropathy in children and adults.

Authors:  N Yoshikawa; H Nakamura; H Ito
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Alteration of lung diffusion capacity in IgA nephropathy.

Authors:  S Ravilly; M Chaussain; J L Iniguez; A Lenhert; G Kalifa; P Brun; P Niaudet; D Gendrel
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.